Rani Therapeutics Holdings Inc Cl A (RANI) Stock Price, Quote & News

Company Profile

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes...

Industry: Biotechnology

Sector: Healthcare

Phone: 408 457 3700

Website: www.ranitherapeutics.com

Address:

2051 Ringwood Avenue, San Jose, United States

Investinyourselff Nov. 14 at 4:36 PM

$RANI Holding with ease. This will run so hard

0 · Reply

boomupwego Nov. 14 at 4:27 PM

$RANI gosh these SSR days are BAS

0 · Reply

Tradelearner2022 Nov. 14 at 4:13 PM

$RANI -Consolidating..

0 · Reply

JZamora01 Nov. 14 at 2:46 PM

$RANI I am impressed this is not dropping massive like other stocks yesterday and today. Holding pretty strong. Thinking of doubling my position.

1 · Reply

TheInside2028 Nov. 14 at 10:18 AM

$RANI jan 2.45//5 calls are a huge buy. 5000 calls were bought yesterday alone. That is going to squeeze the writing of those. Not prudent at all.

0 · Reply

llchen1204 Nov. 14 at 5:56 AM

$RANI

0 · Reply

MoneyGroupLLC Nov. 14 at 4:10 AM

Enter: $RANI Calls Strike Price: $2 Expiry Date: DEC 05 2025 Buy in Price: $0.27 - $0.55 Sell Price: $0.61 Profit : +126% (Turn every $1 into $2.26) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

Creisi Nov. 14 at 2:10 AM

$MLTX $RANI $THAR $TTWO Please Piss off. This message board is for MLTX, it’s no an advertising medium for trash stock ads. Piss off!

1 · Reply

SquidGainz Nov. 13 at 11:54 PM

$MLTX $TTWO $RANI $THAR 6

0 · Reply

DislikePetingtock Nov. 13 at 8:21 PM

$RANI what a bloody day is it? DOW almost down $1000 today.

1 · Reply

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Oct 30, 2025, 8:00 AM EDT - 15 days ago

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

Oct 23, 2025, 4:05 PM EDT - 21 days ago

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Oct 23, 2025, 4:01 PM EDT - 21 days ago

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 20, 2025, 2:20 PM EDT - 24 days ago

Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai

Oct 20, 2025, 9:42 AM EDT - 25 days ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC CRMD RAPT

Oct 17, 2025, 7:48 AM EDT - 4 weeks ago

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Oct 17, 2025, 7:31 AM EDT - 4 weeks ago

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 17, 2025, 7:30 AM EDT - 4 weeks ago

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Aug 7, 2025, 4:05 PM EDT - 3 months ago

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Jul 15, 2025, 9:00 AM EDT - 4 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Jul 14, 2025, 5:00 AM EDT - 4 months ago

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

May 19, 2025, 8:00 AM EDT - 6 months ago

Rani Therapeutics Announces Research Agreement with Chugai

May 13, 2025, 4:05 PM EDT - 6 months ago

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Mar 31, 2025, 7:15 PM EDT - 8 months ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:05 PM EDT - 8 months ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Mar 26, 2025, 4:05 PM EDT - 8 months ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Mar 25, 2025, 6:00 PM EDT - 8 months ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Oct 15, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oct 8, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 3, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in September Investor Conferences

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in August Investor Conferences

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

May 14, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Participate in May Investor Conferences

May 9, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

May 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Mar 20, 2024, 7:05 PM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Mar 15, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Dec 14, 2023, 8:00 AM EST - 2 years ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Nov 8, 2023, 4:05 PM EST - 2 years ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Oct 19, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Oct 12, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Sep 19, 2023, 6:36 AM EDT - 2 years ago

Rani Therapeutics: Excellent Technology But Major Risks Ahead

Sep 18, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

Sep 7, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Aug 11, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Jun 21, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Jun 8, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the Jefferies Healthcare Conference

May 31, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

May 24, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

May 10, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

May 5, 2023, 5:33 PM EDT - 2 years ago

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

Apr 11, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Mar 22, 2023, 6:43 PM EDT - 2 years ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript

Investinyourselff Nov. 14 at 4:36 PM

$RANI Holding with ease. This will run so hard

0 · Reply

boomupwego Nov. 14 at 4:27 PM

$RANI gosh these SSR days are BAS

0 · Reply

Tradelearner2022 Nov. 14 at 4:13 PM

$RANI -Consolidating..

0 · Reply

JZamora01 Nov. 14 at 2:46 PM

$RANI I am impressed this is not dropping massive like other stocks yesterday and today. Holding pretty strong. Thinking of doubling my position.

1 · Reply

TheInside2028 Nov. 14 at 10:18 AM

$RANI jan 2.45//5 calls are a huge buy. 5000 calls were bought yesterday alone. That is going to squeeze the writing of those. Not prudent at all.

0 · Reply

llchen1204 Nov. 14 at 5:56 AM

$RANI

0 · Reply

MoneyGroupLLC Nov. 14 at 4:10 AM

0 · Reply

Creisi Nov. 14 at 2:10 AM

$MLTX $RANI $THAR $TTWO Please Piss off. This message board is for MLTX, it’s no an advertising medium for trash stock ads. Piss off!

1 · Reply

SquidGainz Nov. 13 at 11:54 PM

$MLTX $TTWO $RANI $THAR 6

0 · Reply

DislikePetingtock Nov. 13 at 8:21 PM

$RANI what a bloody day is it? DOW almost down $1000 today.

1 · Reply

KingdomFasho Nov. 13 at 7:01 PM

$RANI let’s get another 2pm pop like yesterday!

0 · Reply

LuckyBoy_PL Nov. 13 at 6:44 PM

$RANI

1 · Reply

wavw Nov. 13 at 6:22 PM

$RANI surprised. Still holding

0 · Reply

Investinyourselff Nov. 13 at 6:19 PM

$RANI Still holding better than other big names

0 · Reply

boomupwego Nov. 13 at 6:12 PM

$RANI woo hoo. Another SSR for today and tomorrow

0 · Reply

KingdomFasho Nov. 13 at 3:48 PM

$RANI ooo… may have a chance to get more shares before the pop😋😅

0 · Reply

KingdomFasho Nov. 13 at 3:04 PM

$RANI Just waking up…

0 · Reply

Tooneyman Nov. 13 at 2:22 PM

$RANI 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

0 · Reply

HeilHiden Nov. 13 at 2:20 PM

$RANI we have over 2300 watchers.

0 · Reply

The_Fifteen_Percent_Guy Nov. 13 at 1:43 PM

📈 ✏️ $RANI On watch today for a breakout, might present for a good swing opportunity on a sub $2 entry > watching

0 · Reply

Kp77_ Nov. 13 at 1:35 PM

$RANI I don’t give an F! I’m holding and buying long term

1 · Reply

squirrelcannon Nov. 13 at 1:14 PM

$RANI any chance they release something today since they did earnings early?

1 · Reply

Market Cap	152.36M
Revenue (ttm)	1.03M
Net Income (ttm)	-30.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,914.56%
Debt to Equity Ratio	-1.88

Volume	5,271,500
Avg Vol	21,988,602
Day's Range	N/A - N/A
Shares Out	71.87M
Stochastic %K	18%
Beta	0.38
Analysts	Strong Sell
Price Target	$9.00